外骨骼物理治疗对亚急性卒中非步行患者的疗效:随机对照试验
该随机对照试验在3家住院康复医院纳入36例亚急性卒中(<3个月)且无法独立行走(FAC 0或1)患者,比较外骨骼物理治疗与标准物理治疗的疗效。意向性分析未发现主要或次要结局在干预后或6个月时存在显著组间差异;外骨骼方案可安全实施,未报告严重不良事件。
要点
- 外骨骼物理治疗未比标准治疗带来更大的步行独立性改善。
- 外骨骼方案可安全用于亚急性卒中非步行患者,无严重不良事件。
- 依从外骨骼方案者6个月时步行恢复更早、步速和6MWT更优,但需谨慎解读。
核心结论
- 外骨骼物理治疗未比标准治疗带来更大的步行独立性改善。
- 外骨骼方案可安全实施,不损害患者结局。
研究设计与样本
- 评估者盲法随机对照试验,在3家住院康复医院开展。
- 纳入36例亚急性卒中(<3个月)且无法在大量辅助下行走(FAC 0或1)患者,随机分为外骨骼组19例和常规治疗组17例。
- 干预持续至出院或最长8周,实验方案以个体化外骨骼训练替代75%的标准物理治疗 sessions。
主要发现
- 意向性分析未发现主要或次要结局在干预后或6个月时存在显著组间差异。
- 5例外骨骼组患者未按计划接受方案,探索性 as-treated 分析显示依从者恢复独立步行更早(p=0.03)、6个月步速(p=0.04)和6MWT(p=0.03)更优。
- per-protocol 分析中上述差异不显著。
- 未报告严重不良事件。
关键数值与推荐
- 主要结局为功能性步行分类(FAC)。
- 次要结局包括步速、6分钟步行试验距离、达到无辅助步行天数、Fugl-Meyer下肢运动功能、Berg平衡量表、患者健康问卷、蒙特利尔认知评估和36项简短健康调查。
- 探索性 as-treated 分析中,依从外骨骼方案者恢复独立步行更早(p=0.03)、6个月步速(p=0.04)和6MWT(p=0.03)更优。
临床怎么用
- 外骨骼物理治疗可作为亚急性卒中非步行患者的安全训练选项,但不应期望其优于标准治疗改善步行独立性。
- 临床决策需结合患者依从性,依从外骨骼方案者可能更早恢复独立步行,但证据来自探索性分析。
局限性
- 样本量小(36例),可能不足以检测组间差异。
- 5例外骨骼组患者未按计划接受方案,依从性影响结果解释。
- 探索性 as-treated 和 per-protocol 分析结果不一致,需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Individuals requiring greater physical assistance to practice walking complete fewer steps in physical therapy during subacute stroke rehabilitation. Powered exoskeletons have been developed to allow repetitious overground gait training for individuals with lower limb weakness. The objective of this study was to determine the efficacy of exoskeleton-based physical therapy training during subacute rehabilitation for walking recovery in non-ambulatory patients with stroke. METHODS: An assessor-blinded randomized controlled trial was conducted at 3 inpatient rehabilitation hospitals. Patients with subacute stroke (< 3 months) who were unable to walk without substantial assistance (Functional Ambulation Category rating of 0 or 1) were randomly assigned to receive exoskeleton-based or standard physical therapy during rehabilitation, until discharge or a maximum of 8 weeks. The experimental protocol replaced 75% of standard physical therapy sessions with individualized exoskeleton-based sessions to increase standing and stepping repetition, with the possibility of weaning off the device. The primary outcome was walking ability, measured using the Functional Ambulation Category. Secondary outcomes were gait speed, distance walked on the 6-Minute Walk Test, days to achieve unassisted gait, lower extremity motor function (Fugl-Meyer Assessment), Berg Balance Scale, Patient Health Questionnaire, Montreal Cognitive Assessment, and 36-Item Short Form Survey, measured post-intervention and after 6 months. RESULTS: Thirty-six patients with stroke (mean 39 days post-stroke) were randomized (Exoskeleton = 19, Usual Care = 17). On intention-to-treat analysis, no significant between-group differences were found in the primary or secondary outcomes at post-intervention or after 6 months. Five participants randomized to the Exoskeleton group did not receive the protocol as planned and thus exploratory as-treated and per-protocol analyses were undertaken. The as-treated analysis found that those adhering to exoskeleton-based physical therapy regained independent walking earlier (p = 0.03) and had greater gait speed (p = 0.04) and 6MWT (p = 0.03) at 6 months; however, these differences were not significant in the per-protocol analysis. No serious adverse events were reported. CONCLUSIONS: This study found that exoskeleton-based physical therapy does not result in greater improvements in walking independence than standard care but can be safely administered at no detriment to patient outcomes. Clinical Trial Registration The Exoskeleton for post-Stroke Recovery of Ambulation (ExStRA) trial was registered at ClinicalTrials.gov (NCT02995265, first registered: December 16, 2016).
引用
- Louie DR, Mortenson WB, Durocher M, et al. Efficacy of an exoskeleton-based physical therapy program for non-ambulatory patients during subacute stroke rehabilitation: a randomized controlled trial. J Neuroeng Rehabil. 2021. PMID: 34629104. doi:10.1186/s12984-021-00942-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。